Form 4: Astrana Health CAO surrenders shares for tax withholding

Astrana Health’s Chief Accounting Officer surrendered 662 shares at $24.27 to cover taxes on RSU vesting, retaining 14,039 shares including unvested awards with time- and performance-based conditions.

Summary

• Glenn Sobotka, Chief Accounting Officer of Astrana Health (ASTH), surrendered 662 common shares on 2026-03-26 to satisfy tax withholding related to RSUs that vested the same day (Transaction Code F).
• The transaction price was $24.27 per share, implying approximately $16,066.74 in tax withholding value.
• After the transaction, beneficial ownership stands at 14,039 shares (including unvested restricted stock noted in the footnotes).
• Unvested time-based restricted stock: 4,824 shares vesting in three equal annual installments beginning 2027-03-26, subject to continued employment.
• Unvested performance-based restricted stock: 8,269 shares vesting upon achievement of specified performance goals.
• The report was signed by Attorney-in-Fact on 2026-03-30.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral insider event: routine tax withholding with continued significant insider ownership and standard vesting structures.

Positives

• Clear visibility into upcoming vesting schedule: 4,824 time-based RSUs vest over three years starting 2027-03-26.
• Insider maintains a meaningful stake of 14,039 shares post-transaction.
• Transaction was a tax-withholding share surrender (Code F), not an open-market sale, minimizing market signal concerns.

Negatives

• Direct ownership decreased by 662 shares due to tax withholding.
• A sizable portion of awards (8,269 shares) remains contingent on performance goal achievement, introducing uncertainty to future realized ownership.

Future Outlook

No forward-looking statements or guidance provided.

Industry Context

StockSavvy.ai notes that insider tax-withholding transactions (Code F) are routine across U.S. public companies and typically neutral in market signaling. Time- and performance-based equity structures remain standard in healthcare services and payer-adjacent sectors to align leadership incentives with retention and performance outcomes.

Comparison to Industry Standards

• Use of Code F share surrender for tax withholding is consistent with common U.S. public company practice across healthcare services peers.
• Blended equity design (time-based RSUs plus performance-contingent awards) aligns with compensation structures seen at healthcare provider-enabler peers such as Privia Health (PRVA) and agilon health (AGL), where multi-year vesting and performance hurdles are standard for senior executives.
• Annual installment vesting beginning one year after grant/initial vest date mirrors broader S&P 1500 executive compensation norms aimed at retention and long-term alignment.

Stakeholder Impact

• Shareholders: Minimal market impact as the transaction was for tax withholding and not an open-market sale.
• Employees/Executives: Clear incentive alignment through time-based and performance-based vesting.
• Market perception: Neutral signal given the administrative nature of the share surrender.

Next Steps

• Time-based RSUs: vest in three equal annual installments starting 2027-03-26, subject to continued employment.
• Performance-based RSUs: vest upon achievement of specified performance goals.

Key Dates

Keywords

Astrana Health, ASTH, Form 4, insider transaction, restricted stock, RSU vesting, tax withholding, Glenn Sobotka, Chief Accounting Officer, beneficial ownership